查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1955106

智慧吸入器市场：市场规模、份额、成长率、行业分析、按类型、应用和地区分類的分析以及未来预测（2026-2034 年）

Smart Inhalers Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 135 Pages | 商品交期: 请询问到货日

价格

智慧吸入器市场的成长要素

受数位药物传输系统技术进步和呼吸系统疾病日益增长的推动，全球智慧吸入器市场正经历显着增长。根据 Fortune Business Insights 预测，该市场规模预计将在 2025 年达到 2.2198 亿美元，2026 年达到 3.1411 亿美元，到 2034 年将飙升至 53.4562 亿美元，在 2026 年至 2034 年将飙升至 53.4562 亿美元，在 2026 年至 2034 年将飙升至 25% (GR2%) 将达到 425% (GR2%) 年增长率的预测期。北美地区预计将在 2025 年占据市场主导地位，市场份额将达到 67.74%，这主要得益于数位医疗的普及、政府的支持性政策以及公共和私人对智慧吸入器技术的大量投资。

市场概况及成长要素

智慧吸入器是一种内建感测器的医疗设备，可连接到智慧型手机和其他数位平台，用于监测患者的健康状况，特别是患有气喘和慢性阻塞性肺病（COPD）等疾病的患者。这些设备可以追踪药物使用情况、剂量和患者依从性，并就空气污染和花粉症等环境因素发出警报。

慢性呼吸系统疾病盛行率的上升以及人们对预防医学日益重视是推动市场成长的主要因素。例如，美国疾病管制与预防中心（CDC）的数据显示，超过2500万美国人患有气喘，凸显了需要精准药物管理的患者群体不断扩大。此外，智慧吸入器的引入已被证明可以减少住院和门诊就诊次数，从而改善治疗效果并加速市场渗透。

市场趋势

智慧吸入器市场正经历数位化技术的快速融合。定量喷雾吸入器（MDI）和干粉吸入器（DPI）等设备现在都配备了蓝牙感测器，可提供剂量监测和提醒功能。主要企业正大力投资研发，以推出基于MDI的创新智慧吸入器。例如，2024年11月，Lupin公司发布了ADHERO，这是一款针对急性呼吸系统疾病患者的智慧MDI设备，可提高患者的用药依从性并实现使用监测。

市场限制因素

儘管存在这些优势，市场成长仍面临挑战。尤其是在发展中地区，人们对数位吸入器的认知度仍然较低，传统吸入器仍被用作替代方案。此外，新兴经济体的技术壁垒和可及性问题也可能减缓数位吸入器的普及。

细分市场分析

  • 按产品类别划分：预计到2026年，基于定量吸入器（MDI）的智慧吸入器将占据68.86%的市场份额（2.163亿美元），凭藉其卓越的剂量监测和控制能力，保持主导地位。虽然基于干粉吸入器（DPI）的吸入器保持着稳定的市场份额，但剂量变异性等技术问题正透过持续的研发得到解决。
  • 疾病细分：2026年，气喘领域将引领市场，占据57.99%的市场份额（1.8213亿美元），主要得益于全球气喘盛行率的上升。慢性阻塞性肺病（COPD）领域预计将保持稳定成长，这主要得益于智慧吸入器在日常疾病监测中的应用。
  • 分销管道：医院药房凭藉其便利性和与生产商的合作关係占据主导地位。同时，随着非处方数位吸入器获得FDA核准，零售药局预计到2026年将占据37.70%的市场份额（1.1841亿美元）。

区域洞察

北美地区在2025年以1.5037亿美元的市场规模引领全球市场，主要得益于医疗保健数位化、有利的政策以及强劲的公私投资。预计到2026年，美国市场规模将达到1.996亿美元。欧洲市场呈现稳定成长态势，预计2026年，英国和德国市场规模将分别达到1,860万美元和755万美元，主要得益于数位化医疗设备的普及应用。亚太地区预计将经历快速成长，预计到2026年，日本市场规模将达到1,358万美元，中国将达到562万美元，印度将达到398万美元，这主要得益于供应商渗透率的提高和医疗保健IT领域投资的增加。

主要企业及趋势

市场仍在发展中，但竞争异常激烈，主要参与者包括Adherium、Propeller Health、Cohero Health Inc.、葛兰素史克、阿斯利康、诺华、3M、梯瓦製药和Vectura集团。每家公司都专注于研发、数位整合和策略合作，以巩固其市场地位。关键进展包括Propeller Health于2020年与诺华合作，为日本市场推出数位健康平台；以及Aptar集团与松摩尔在中国数位疗法业务领域展开合作。同样在2020年，梯瓦呼吸系统公司（Teva Respiratory）的「ArmonAir Digihaler」获得了FDA核准，这是一款用于气喘患者的扩展型数位吸入解决方案。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会

第四章 主要考虑因素

  • 近期产业趋势：企业合併等。
  • 主要国家的监管状况
  • 与智慧吸入器相关的技术进步
  • 智慧吸入器产业背景
  • 主要行业趋势
  • 新产品发布

第五章：全球智慧吸入器市场分析、洞察与预测（2021-2034）

  • 主要分析结果/总结
  • 市场分析、洞察与预测：按产品分类
    • 干粉吸入器（DPI）吸入器
    • 基于定量喷雾吸入器（MDI）的吸入器
  • 市场分析、洞察与预测：按疾病类型划分
    • 气喘
    • 慢性阻塞性肺病（COPD）
  • 市场分析、洞察与预测：按分销管道划分
    • 医院药房
    • 零售药房
    • 线上管道
  • 市场分析、洞察与预测：按地区划分
    • 北美洲
    • 欧洲
    • 亚太地区
    • 世界其他地区（RoW）

第六章：北美智慧吸入器市场分析：洞察与预测（2021-2034）

  • 国家
    • 我们
    • 加拿大

第七章：欧洲智慧吸入器市场分析：洞察与预测（2021-2034）

  • 国家
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 其他欧洲国家

第八章：亚太地区智慧吸入器市场分析：洞察与预测（2021-2034）

  • 国家
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 其他亚太地区

第九章：其他地区（ROW）智慧吸入器市场分析：洞察与预测（2021-2034 年）

第十章 竞争分析

  • 主要行业趋势
  • 全球市占率分析（2021）
  • 竞争对手仪錶板
  • 主要企业比较分析
  • 公司简介
    • Adherium
    • Propeller Health
    • Cohero Health Inc.
    • GlaxoSmithKline
    • AstraZeneca plc
    • Novartis AG
    • 3M Company
    • Teva Pharmaceuticals
    • Vectura Group
    • Others

第十一章 策略建议

Product Code: FBI102705

Growth Factors of smart inhalers Market

The global smart inhalers market is witnessing significant growth, driven by technological advancements in digital drug delivery systems and the rising prevalence of respiratory diseases. According to Fortune Business Insights, the market was valued at USD 221.98 million in 2025, is projected to reach USD 314.11 million in 2026, and is expected to soar to USD 5,345.62 million by 2034, exhibiting a robust CAGR of 42.52% during the forecast period from 2026 to 2034. North America dominated the market in 2025 with a 67.74% share, driven by digital healthcare adoption, supportive government policies, and significant public and private funding for smart inhaler technologies.

Market Overview and Growth Drivers

Smart inhalers are medical devices integrated with sensors that connect to smartphones or other digital platforms to monitor patients' health, particularly for conditions such as asthma and chronic obstructive pulmonary disease (COPD). These devices track medication usage, dosage, and patient adherence, while providing alerts for environmental triggers like pollution or high pollen counts.

The rising prevalence of chronic respiratory diseases and increased focus on preventive care are key drivers of market growth. For instance, as per CDC data, over 25 million Americans suffer from asthma, highlighting a growing patient pool requiring precise medication management. Moreover, the adoption of smart inhalers has been shown to reduce hospitalization and doctor visits, enhancing procedural outcomes and encouraging broader market adoption.

Market Trends

The smart inhalers market is experiencing rapid digital integration. Devices like metered-dose inhalers (MDI) and dry powder inhalers (DPI) now include Bluetooth-enabled sensors for dose monitoring and reminders. Major companies are investing heavily in R&D to launch innovative MDI-based smart inhalers. For instance, in November 2024, Lupin introduced ADHERO, a smart MDI device for acute respiratory patients to improve adherence and monitor usage.

Market Restraints

Despite the advantages, market growth faces challenges. Manual inhalers continue to serve as substitutes, particularly in developing regions where awareness of digital inhalers remains limited. Additionally, technical and accessibility barriers in emerging economies may slow adoption.

Segment Analysis

  • By Product: MDI-based smart inhalers dominated in 2026 with 68.86% market share (USD 216.3 million), owing to superior dosage monitoring and control features. DPI-based inhalers maintain a stable market presence, though technical issues like inconsistent dosage are being addressed through ongoing R&D.
  • By Disease Indication: The asthma segment led the market in 2026, accounting for 57.99% share (USD 182.13 million) due to increasing prevalence globally. The COPD segment is projected to grow steadily, supported by the adoption of smart inhalers for regular disease monitoring.
  • By Distribution Channel: Hospital pharmacies hold a dominant position due to accessibility and partnerships with manufacturers, while retail pharmacies achieved 37.70% share (USD 118.41 million) in 2026, aided by FDA approvals for over-the-counter digital inhalers.

Regional Insights

North America led the global market in 2025 with USD 150.37 million, driven by healthcare digitalization, favorable policies, and strong private and public investments. The U.S. market is projected to reach USD 199.6 million by 2026. Europe shows steady growth, with the U.K. and Germany markets projected at USD 18.6 million and USD 7.55 million in 2026, respectively, due to the adoption of digital medical devices. Asia Pacific is anticipated to grow rapidly, with Japan at USD 13.58 million, China at USD 5.62 million, and India at USD 3.98 million by 2026, supported by increasing vendor penetration and healthcare IT investments.

Key Industry Players and Developments

The market is nascent yet competitive, with key players such as Adherium, Propeller Health, Cohero Health Inc., GlaxoSmithKline, AstraZeneca, Novartis AG, 3M, Teva Pharmaceuticals, and Vectura Group. Companies are focusing on R&D, digital integration, and strategic collaborations to enhance their market position. Notable developments include Propeller Health's partnership with Novartis in 2020 to introduce a digital health platform in Japan and AptarGroup's collaboration with Sonmol for digital therapies in China. Teva Respiratory received FDA approval in 2020 for ArmonAir Digihaler, expanding digital inhalation solutions for asthma patients.

Conclusion

The global smart inhalers market is poised for exponential growth between 2025 and 2034, driven by rising respiratory disease prevalence, technological advancements, and increasing adoption of digital health devices. While the presence of manual inhalers and limited awareness in developing regions may restrain growth, innovations in MDI-based devices, hospital and retail pharmacy partnerships, and supportive regulatory frameworks are expected to significantly accelerate market adoption. North America remains the dominant market, while Asia Pacific offers substantial growth potential owing to emerging economies and digital healthcare expansion. The market trajectory highlights the critical role of smart inhalers in improving patient adherence, reducing healthcare costs, and enhancing respiratory disease management worldwide.

Segmentation By Product

  • Dry Powder Inhaler (DPI)- based Inhalers
  • Metered Dose Inhaler (MDI)- based Inhalers

By Disease indication

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channel

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, and Rest of Asia- Pacific)
  • Rest of the world (Row)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Recent Industry Developments Such as Mergers & Acquisitions
  • 4.2. Regulatory Scenario for Key Countries
  • 4.3. Technological Advancements Pertaining to Smart Inhalers
  • 4.4. Industry Background Pertaining to Smart Inhalers
  • 4.5. Key Industry Trends
  • 4.6. New Product Launch

5. Global Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product
    • 5.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 5.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 5.3. Market Analysis, Insights and Forecast - By Disease indication
    • 5.3.1. Asthma
    • 5.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 5.4.1. Hospital Pharmacies
    • 5.4.2. Retail Pharmacies
    • 5.4.3. Online Channel
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World (RoW)

6. North America Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis, Insights and Forecast - By Product
    • 6.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 6.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 6.3. Market Analysis, Insights and Forecast - By Disease indication
    • 6.3.1. Asthma
    • 6.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 6.4.1. Hospital Pharmacies
    • 6.4.2. Retail Pharmacies
    • 6.4.3. Online Channel
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis, Insights and Forecast - By Product
    • 7.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 7.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 7.3. Market Analysis, Insights and Forecast - By Disease indication
    • 7.3.1. Asthma
    • 7.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Retail Pharmacies
    • 7.4.3. Online Channel
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub Region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Rest of Europe

8. Asia Pacific Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis, Insights and Forecast - By Product
    • 8.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 8.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 8.3. Market Analysis, Insights and Forecast - By Disease indication
    • 8.3.1. Asthma
    • 8.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 8.4.1. Hospital Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Channel
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub Region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Rest of Asia Pacific

9. Rest of the World Smart Inhalers Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis, Insights and Forecast - By Product
    • 9.2.1. Dry Powder Inhaler (DPI)- based Inhalers
    • 9.2.2. Metered Dose Inhaler (MDI)- based Inhalers
  • 9.3. Market Analysis, Insights and Forecast - By Disease indication
    • 9.3.1. Asthma
    • 9.3.2. Chronic Obstructive Pulmonary Disease (COPD)
  • 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
    • 9.4.1. Hospital Pharmacies
    • 9.4.2. Retail Pharmacies
    • 9.4.3. Online Channel

10. Competitive Analysis

  • 10.1. Key Industry Developments
  • 10.2. Global Market Share Analysis (2021)
  • 10.3. Competition Dashboard
  • 10.4. Comparative Analysis - Major Players
  • 10.5. Company Profiles
    • 10.5.1. Adherium
      • 10.5.1.1. Overview,
      • 10.5.1.2. Products & services,
      • 10.5.1.3. SWOT analysis,
      • 10.5.1.4. Recent developments,
      • 10.5.1.5. strategies,
      • 10.5.1.6. financials (based on availability)
    • 10.5.2. Propeller Health
      • 10.5.2.1. Overview,
      • 10.5.2.2. Products & services,
      • 10.5.2.3. SWOT analysis,
      • 10.5.2.4. Recent developments,
      • 10.5.2.5. strategies,
      • 10.5.2.6. financials (based on availability)
    • 10.5.3. Cohero Health Inc.
      • 10.5.3.1. Overview,
      • 10.5.3.2. Products & services,
      • 10.5.3.3. SWOT analysis,
      • 10.5.3.4. Recent developments,
      • 10.5.3.5. strategies,
      • 10.5.3.6. financials (based on availability)
    • 10.5.4. GlaxoSmithKline
      • 10.5.4.1. Overview,
      • 10.5.4.2. Products & services,
      • 10.5.4.3. SWOT analysis,
      • 10.5.4.4. Recent developments,
      • 10.5.4.5. strategies,
      • 10.5.4.6. financials (based on availability)
    • 10.5.5. AstraZeneca plc
      • 10.5.5.1. Overview,
      • 10.5.5.2. Products & services,
      • 10.5.5.3. SWOT analysis,
      • 10.5.5.4. Recent developments,
      • 10.5.5.5. strategies,
      • 10.5.5.6. financials (based on availability)
    • 10.5.6. Novartis AG
      • 10.5.6.1. Overview,
      • 10.5.6.2. Products & services,
      • 10.5.6.3. SWOT analysis,
      • 10.5.6.4. Recent developments,
      • 10.5.6.5. strategies,
      • 10.5.6.6. financials (based on availability)
    • 10.5.7. 3M Company
      • 10.5.7.1. Overview,
      • 10.5.7.2. Products & services,
      • 10.5.7.3. SWOT analysis,
      • 10.5.7.4. Recent developments,
      • 10.5.7.5. strategies,
      • 10.5.7.6. financials (based on availability)
    • 10.5.8. Teva Pharmaceuticals
      • 10.5.8.1. Overview,
      • 10.5.8.2. Products & services,
      • 10.5.8.3. SWOT analysis,
      • 10.5.8.4. Recent developments,
      • 10.5.8.5. strategies,
      • 10.5.8.6. financials (based on availability)
    • 10.5.9. Vectura Group
      • 10.5.9.1. Overview,
      • 10.5.9.2. Products & services,
      • 10.5.9.3. SWOT analysis,
      • 10.5.9.4. Recent developments,
      • 10.5.9.5. strategies,
      • 10.5.9.6. financials (based on availability)
    • 10.5.10. Others
      • 10.5.10.1. Overview,
      • 10.5.10.2. Products & services,
      • 10.5.10.3. SWOT analysis,
      • 10.5.10.4. Recent developments,
      • 10.5.10.5. strategies,
      • 10.5.10.6. financials (based on availability)

11. Strategic Recommendations

List of Tables

  • Table 1: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 2: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 3: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 4: Global Smart Inhalers Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 5: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 6: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 7: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 8: North America Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 9: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 10: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 11: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 12: Europe Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 14: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 15: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034
  • Table 16: Asia Pacific Smart Inhalers Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Product, 2021-2034
  • Table 18: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Disease indication, 2021-2034
  • Table 19: Rest of the World (RoW) Smart Inhalers Market Revenue (US$ Mn) Forecast, by Distribution Channel 2021-2034

List of Figures

  • Figure 1: Global Smart Inhalers Market Revenue Breakdown (US$ Mn, %) by Region, 2021 & 2034
  • Figure 2: Global Smart Inhalers Market Value Share (%), by Product, 2021 & 2034
  • Figure 3: Global Smart Inhalers Market Forecast (US$ Mn), by Dry Powder Inhaler (DPI)- based Inhalers,2021-2034
  • Figure 4: Global Smart Inhalers Market Forecast (US$ Mn), by Metered Dose Inhaler (MDI)- based Inhalers,2021-2034
  • Figure 5: Global Smart Inhalers Market Value Share (%), by Disease indication, 2021 & 2034
  • Figure 6: Global Smart Inhalers Market Forecast (US$ Mn), by Asthma, 2021-2034
  • Figure 7: Global Smart Inhalers Market Forecast (US$ Mn), by Chronic Obstructive Pulmonary Disease (COPD), 2021-2034
  • Figure 8: Global Smart Inhalers Market Value Share (%), by Distribution Channel 2021 & 2034
  • Figure 9: Global Smart Inhalers Market Forecast (US$ Mn), by Hospital Pharmacies, 2021-2034
  • Figure 10: Global Smart Inhalers Market Forecast (US$ Mn), by Retail Pharmacies 2021-2034
  • Figure 11: Global Smart Inhalers Market Forecast (US$ Mn), by Online Channel, 2021-2034
  • Figure 12: Global Smart Inhalers Market Value (US$ Mn), by Region, 2021 & 2034
  • Figure 13: North America Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 14: North America Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 15: North America Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 16: North America Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 17: North America Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 18: North America Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 19: North America Smart Inhalers Market Value (US$ Mn), By Country, 2021 & 2034
  • Figure 20: North America Smart Inhalers Market Value Share (%), By Country, 2021
  • Figure 21: Europe Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 22: Europe Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 23: Europe Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 24: Europe Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 25: Europe Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 26: Europe Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 27: Europe Smart Inhalers Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 28: Europe Smart Inhalers Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 29: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 30: Asia Pacific Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 31: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 32: Asia Pacific Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 33: Asia Pacific Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 34: Asia Pacific Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 35: Asia Pacific Smart Inhalers Market Value (US$ Mn), By Country/ Sub-region, 2021 & 2034
  • Figure 36: Asia Pacific Smart Inhalers Market Value Share (%), By Country/ Sub-region, 2021
  • Figure 37: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Product, 2021 & 2034
  • Figure 38: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Product, 2021
  • Figure 39: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Disease indication, 2021 & 2034
  • Figure 40: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Disease indication, 2021
  • Figure 41: Rest of the World (RoW) Smart Inhalers Market Value (US$ Mn), by Distribution Channel 2021 & 2034
  • Figure 42: Rest of the World (RoW) Smart Inhalers Market Value Share (%), by Distribution Channel 2021
  • Figure 43: Global Smart Inhalers Market Share (%), By Company, 2021